Factors including types of breast cancer, length of follow-up, types of YKL-40 (secreted versus tumor cell-associated), ethnic origin, sample number, or other factors may account for the disparate results and warrant further studies. The gene discussed is CHI3L1; the disease is breast carcinoma.